Delivery Order SPE2DB24D6041-SPE2DB25FKCLA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,978.92 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings under a firm fixed-price contract. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and represents a non-set-aside, competitively awarded delivery order. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,323.44 to AmerisourceBergen Drug Corp for Annovera vaginal rings on March 11, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of March 12, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical supply chain....
- The Defense Logistics Agency awarded a delivery order valued at $2,302.29 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 23, 2025, with a completion date of September 24, 2025. The contract utilizes firm fixed pricing under a non-competitive, non-set-aside delivery order mechanism. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,620.00 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,506.26 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,373.73 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. Annovera is a long-acting contraceptive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,253.13 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Annovera vaginal rings. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, to be performed at the contractor's location in Conshohocken, Pennsylvania. The award was not set aside for any particular business category and represents a competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency has awarded a delivery order valued at $2,387.01 to AmerisourceBergen Drug Corp for Annovera vaginal rings. This is a firm fixed-price, competitively awarded contract with a completion date of September 23, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order totaling $1,377.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on June 2, 2025, with completion expected by June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,205.16 to AmerisourceBergen Drug Corp for Annovera vaginal rings on June 17, 2025, with completion scheduled for June 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken,...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCLADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,295.78 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA and is being performed at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, reflecting open competition in the procurement process. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems worldwide. The Annovera vaginal ring delivery is representative of the company's role in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains for DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/13/25 |